Search results
Norman Edward "Ned" Sharpless (born September 20, 1966) is the previous Director of the National Cancer Institute (NCI). Before that, Sharpless was Professor of Medicine and Genetics Chair, Director of University of North Carolina UNC Lineberger Comprehensive Cancer Center, Molecular Therapeutics, Wellcome Distinguished Professorship in Cancer ...
Dec 7, 2021 · With cancer still among the leading causes of death for Americans, 4 Dr. Sharpless notes that it remains a national health concern. (As of Nov. 4, 2021, lung cancer was the leading cause of cancer death in the United States, accounting for nearly 140,000 deaths in the year 2019.
- Ashley Hay BSN, RN
- 127, Issue24
- 07 December 2021
Apr 4, 2022 · Norman “Ned” Sharpless, director of the $6.9 billion National Cancer Institute (NCI) since late 2017, announced today that he will step down at the end of this month after nearly 5 years on the job. Sharpless’s announcement stunned many in the cancer research community.
Apr 4, 2022 · Norman E. “Ned” Sharpless, M.D., announced today that he has decided to step down from his position as director of the National Cancer Institute (NCI), part of the National Institutes of Health, a position he has held since 2017.
Apr 4, 2022 · Norman E. “Ned” Sharpless, M.D., announced today that he has decided to step down from his position as director of the National Cancer Institute (NCI), part of the National Institutes of Health, a position he has held since 2017. Dr. Sharpless will continue as NCI director through April 29, 2022, to allow for a thorough transition.
Apr 4, 2022 · Norman “Ned” Sharpless, the director of the National Cancer Institute who had a short stint leading the Food and Drug Administration, announced Monday that he is stepping down at the end of...
Apr 6, 2022 · Norman E. “Ned” Sharpless, M.D., announced last week that he will step down as director of the National Cancer Institute (NCI), part of the National Institutes of Health, at the end of the month. NCI Principal Deputy Director Douglas R. Lowy, M.D., will serve as NCI’s acting director effective April 30, 2022.
